Patents by Inventor Toshiharu Hanaya

Toshiharu Hanaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • External dermatological agent for anti-ageing
    Patent number: 10071042
    Abstract: The present invention aims to provide an external dermal composition for anti-ageing, which prevents or improves apparent skin problems such as age-related or senescent wrinkles, fine wrinkles, saggings, spots, etc., as well as maintaining or enhancing the skin barrier functions. The object is solved by providing an external dermal agent for anti-ageing, which contains as an effective ingredient(s) one or more members selected from the group consisting of adenosine N1-oxide 5?-phosphate, analogs thereof, and their salts.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: September 11, 2018
    Assignee: HAYASHIBARA CO., LTD.
    Inventors: Keizo Kohno, Satomi Miyata, Toshiharu Hanaya, Shigeharu Fukuda
  • EXTERNAL DERMATOLOGICAL AGENT FOR ANTI-AGEING
    Publication number: 20170035676
    Abstract: The present invention aims to provide an external dermal composition for anti-ageing, which prevents or improves apparent skin problems such as age-related or senescent wrinkles, fine wrinkles, saggings, spots, etc., as well as maintaining or enhancing the skin barrier functions. The object is solved by providing an external dermal agent for anti-ageing, which contains as an effective ingredient(s) one or more members selected from the group consisting of adenosine N1-oxide 5?-phosphate, analogues thereof, and their salts.
    Type: Application
    Filed: April 13, 2015
    Publication date: February 9, 2017
    Inventors: Keizo KOHNO, Satomi MIYATA, Toshiharu HANAYA, Shigeharu FUKUDA
  • Fluid for peritoneal dialysis
    Patent number: 9066968
    Abstract: The present invention has an object to provide a fluid for peritoneal dialysis with satisfactory body fluid removability, high biocompatibility, and improved storage stability, and the object is attained by a fluid for peritoneal dialysis containing one or more saccharides selected from cyclonigerosylnigerose, cyclomaltosylmaltose, and L-ascorbic acid 2-glucoside.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: June 30, 2015
    Assignee: HAYASHIBARA CO. LTD
    Inventors: Hitomi Ohta, Toshiharu Hanaya, Shigeharu Fukuda, Yoshikatsu Miwa, Toshio Miyake
  • FLUID FOR PERITONEAL DIALYSIS
    Publication number: 20140148409
    Abstract: The present invention has an object to provide a fluid for peritoneal dialysis with satisfactory body fluid removability, high biocompatibility, and improved storage stability, and the object is attained by a fluid for peritoneal dialysis containing one or more saccharides selected from cyclonigerosylnigerose, cyclomaltosylmaltose, and L-ascorbic acid 2-glucoside.
    Type: Application
    Filed: January 31, 2014
    Publication date: May 29, 2014
    Applicant: HAYASHIBARA CO. LTD
    Inventors: Hitomi OHTA, Toshiharu HANAYA, Shigeharu FUKUDA, Yoshikatsu MIWA, Toshio MIYAKE
  • FLUID FOR PERITONEAL DIALYSIS
    Publication number: 20090023684
    Abstract: The present invention has an object to provide a fluid for peritoneal dialysis with satisfactory body fluid removability, high biocompatibility, and improved storage stability, and the object is attained by a fluid for peritoneal dialysis containing one or more saccharides selected from cyclonigerosylnigerose, cyclomaltosylmaltose, and L-ascorbic acid 2-glucoside.
    Type: Application
    Filed: April 13, 2006
    Publication date: January 22, 2009
    Inventors: Hitomi Ohta, Toshiharu Hanaya, Shigeharu Fukuda, Yoshikatsu Miwa, Toshio Miyake
  • Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator
    Publication number: 20050054585
    Abstract: A process for producing a polyether polymer by polymerizing a monomer having an oxirane group in the presence of a Lewis base having no active hydrogen such as, for example, a nitrile compound, a cyclic ether compound or an ester compound; and a polyether polymer produced by this process. Thus, a polyether polymer having a minimized amount of undesirable crosslinked product can be produced without reduction of polymerization activity.
    Type: Application
    Filed: October 11, 2002
    Publication date: March 10, 2005
    Inventors: Toshio Ariyasu, Toshiharu Hanaya, Shigeyuki Arai, Masao Ikeda, Masashi Kurimoto
  • Trehalose receptor and method for detecting trehalose with the same
    Publication number: 20050048508
    Abstract: Disclosed are a mammalian trehalose receptor which comprises a protein comprising any of the amino acid sequences of SEQ ID NOs: 1, 2, 3 and 5; or a protein comprising any of the amino acid sequences of SEQ ID NOs: 1, 4 and 5; and a method for detecting trehalose using an animal cell in which the trehalose receptor has been expressed.
    Type: Application
    Filed: September 17, 2003
    Publication date: March 3, 2005
    Applicant: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
    Inventors: Toshio Ariyasu, Shuji Matsumoto, Fumiyo Kyono, Toshiharu Hanaya, Shigeyuki Arai, Masao Ikeda, Masashi Kurimoto
  • Muscosal immunoregulatory agent and its use
    Publication number: 20040127455
    Abstract: A mucosal immunoregulatory agent comprising trehalose, which has neither excessive stress nor care for side effects even when administrated repeatedly, is administered and provides mucosal immunoregulatory activity.
    Type: Application
    Filed: January 29, 2004
    Publication date: July 1, 2004
    Applicant: KABUSHIKI Kaisha Hayashibara Seibutsu KK
    Inventors: Norie Arai, Toshiharu Hanaya, Shigeyuki Arai, Masashi Kurimoto
  • Mucosal immunomodulator and use thereof
    Publication number: 20030003132
    Abstract: The object of the present invention is to provide a mucosal immunoregulatory agent which has neither excessive stress nor care for side effects even when administrated repeatedly, and solves the objected by providing the mucosal immunoregulatory agent comprising trehalose.
    Type: Application
    Filed: July 8, 2002
    Publication date: January 2, 2003
    Inventors: Norie Arai, Toshiharu Hanaya, Shigeyuki Arai, Masashi Kurimoto